2025-08-11 - Analysis Report
Okay, here's a comprehensive analysis of Merck & Co Inc (MRK) based on the provided data, presented in a structured format suitable for a report.

**Report: Merck & Co Inc (MRK) Analysis**

**Company Overview:** Merck & Co Inc is a global pharmaceutical company that develops and markets a wide range of healthcare products.

**1. Performance vs. S&P 500 (VOO) Analysis**

*   **Key Figures:**
    *   MRK Cumulative Return: -9.90%
    *   VOO Cumulative Return: 84.01%
    *   Deviation (MRK - VOO): -93.91%
    *   Deviation Range: Max 40.3, Min -93.6
    *   Relative Deviation: 1.0

*   **Analysis:**
    *   MRK has significantly underperformed the S&P 500 (VOO) over the analyzed period. The -93.91% cumulative return difference highlights substantial underperformance. The relative deviation of 1.0 suggests MRK's performance is near the lower end of its historical deviation range compared to the S&P 500.

*   **Alpha, Beta Analysis:**

    | Year       | CAGR     | MDD      | Alpha    | Beta   | Cap(B) |
    | ---------- | -------- | -------- | -------- | ------ | ------ |
    | 2015-2017  | 5.0%     | 58.2%    | 2.0%     | -0.2   | 134.1  |
    | 2016-2018  | 43.0%    | 66.4%    | 47.0%    | 0.1    | 182.1  |
    | 2017-2019  | 40.0%    | 66.4%    | 18.0%    | 0.0    | 216.8  |
    | 2018-2020  | 20.0%    | 66.4%    | -7.0%    | 0.1    | 195.0  |
    | 2019-2021  | -1.0%    | 65.6%    | -51.0%   | 0.0    | 191.4  |
    | 2020-2022  | 13.0%    | 69.5%    | 6.0%     | 0.0    | 277.1  |
    | 2021-2023  | 31.0%    | 69.5%    | 11.0%    | 0.2    | 272.3  |
    | 2022-2024  | -7.0%    | 69.5%    | -34.0%   | 0.2    | 248.5  |
    | 2023-2025  | -62.0%   | 62.0%    | -111.0%  | 0.4    | 201.6  |

*   **Analysis of Alpha, Beta Table:**
    *   **CAGR:** Varies significantly, with recent periods (2023-2025) showing substantial negative growth (-62.0%).
    *   **MDD:** High Maximum Drawdown values indicate significant risk and volatility.
    *   **Alpha:** Mostly positive in earlier periods, indicating outperformance relative to the benchmark, but deeply negative in recent periods (2019-2021, 2022-2024, 2023-2025), suggesting significant underperformance.
    *   **Beta:** Generally low (close to 0), suggesting MRK's price movement is not strongly correlated with the market. The recent Beta increase to 0.4 may indicate increasing sensitivity to market movements.
    *   **Cap(B):** Market capitalization has fluctuated, showing growth then recent decline.

**2. Recent Stock Price Movement**

*   **Key Figures:**
    *   Current Price: $80.69
    *   Previous Close: $80.37
    *   Change: +$0.40
    *   5-Day Moving Average: $80.23
    *   20-Day Moving Average: $81.49
    *   60-Day Moving Average: $79.96

*   **Analysis:**
    *   The stock price is slightly up from the previous close.
    *   The price is currently above the 5-day and 60-day moving averages but below the 20-day moving average. This suggests a potential short-term upward trend but caution is warranted as it remains below the 20-day MA. The small change ($0.40) is not a significant price movement, so no extreme volatility concerns are immediately apparent.

**3. Technical Indicators and Expected Return**

*   **Key Figures:**
    *   Market Risk Indicator (MRI): 0.3323 (Low Risk)
    *   RSI: 53.99
    *   PPO: -0.35
    *   Hybrid Signal: cash_69%_Sell 1.3% of holdings
    *   Delta_Previous_Relative_Divergence (20-day): 1.0 (+)
    *   Expected Return: 246.3%

*   **Analysis:**
    *   **MRI:** The Market Risk Indicator is in the "Low Risk" range, suggesting a stable market environment for MRK.
    *   **RSI:** An RSI of 53.99 is neutral, not indicating overbought or oversold conditions.
    *   **PPO:** A negative PPO (-0.35) suggests that the short-term moving average is below the long-term moving average, which can be a bearish signal, but its very close to 0, so bearish indication is weak.
    *   **Hybrid Signal:** The hybrid signal recommends a high cash position (69%) and a small sell-off (1.3%). This is a cautionary signal, aligning with the MRI indication.
    *   **Delta_Previous_Relative_Divergence:**  The positive change in relative divergence suggests a short-term upward trend.
    *   **Expected Return:** A very high expected return (246.3%) is projected if holding the stock for a long time. This figure should be critically evaluated; it may be an outlier or based on specific model assumptions. It warrants further investigation of the underlying methodology and assumptions.

**4. Recent News & Significant Events:**

*   **Summary:** Recent news indicates volatility, discussions about performance, and highlights of both risks and opportunities for Merck & Co Inc (MRK).
*   **Impact:** These events suggest that the company is experiencing significant market attention. Investors should closely monitor further developments.

**5. Recent Earnings Analysis:**

| 날짜       | EPS  | 매출         |
| ---------- | ---- | ------------ |
| 2025-08-05 | 1.76 | 15.81 B$     |
| 2025-05-02 | 2.01 | 15.53 B$     |
| 2024-11-06 | 1.25 | 16.66 B$     |
| 2024-08-05 | 2.15 | 16.11 B$     |
| 2025-08-05 | 2.15 | 16.11 B$     |

*   **Analysis:**
    *   Earnings Per Share (EPS) has fluctuated. The most recent EPS is 1.76.
    *   Revenue also shows some fluctuation, with a recent decrease to 15.81B$.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue     | Profit Margin |
| ---------- | ----------- | ------------- |
| 2025-06-30 | $15.81B     | 77.50%        |
| 2025-03-31 | $15.53B     | 77.98%        |
| 2024-12-31 | $15.62B     | 75.50%        |
| 2024-09-30 | $16.66B     | 75.51%        |
| 2024-06-30 | $16.11B     | 76.76%        |

**Capital and Profitability:**

| Quarter    | Equity      | ROE      |
| ---------- | ----------- | -------- |
| 2025-06-30 | $48.99B     | 9.04%    |
| 2025-03-31 | $48.34B     | 10.51%   |
| 2024-12-31 | $46.31B     | 8.08%    |
| 2024-09-30 | $44.50B     | 7.09%    |
| 2024-06-30 | $43.58B     | 12.52%   |

*   **Analysis:**
    *   **Revenue:** The revenue is relatively stable but shows some fluctuations quarter to quarter.
    *   **Profit Margin:** Profit margins are consistently high, indicating strong profitability.
    *   **Equity:** Equity has been increasing, suggesting a growing asset base.
    *   **ROE:** Return on Equity shows variability, peaking in 2024-06-30 and then decreasing, suggesting fluctuating efficiency in generating profits from equity.

**7. Overall Summary and Conclusion:**

*   **Underperformance:** MRK has significantly underperformed the S&P 500, indicated by a large negative cumulative return difference.
*   **Volatility:** High MDD values indicate the stock's price experiences significant swings.
*   **Recent Trends:**  Recent earnings show some fluctuation. The stock price is showing a slight upward trend based on moving averages and divergence change, but caution is advised.
*   **Financial Health:** The company has strong and stable profit margins.
*   **Hybrid Signal:** The hybrid signal indicates a cautionary stance, recommending a high cash position.
*   **Expected Return:** A very high expected return is suggested, but this value requires further validation.
*   **Recommendation:** Given the underperformance relative to the S&P 500, recent volatility, and cautionary signals, investors should exercise caution. Further investigation into the drivers behind the underperformance and the validity of the high expected return is warranted before making investment decisions. Closely monitor the company's performance and announcements in light of the recent news and significant events.
